A r t i c l e s BATF and BATF3, two members of the AP-1 family of transcription factors, provide distinct lineage-specific functions in the immune system 1,2 . BATF3 is required specifically for development of the CD8α + lymphoid-resident dendritic cell (DC) subset responsible for cross-presentation in vivo 1 and of the related CD103 + peripheral DC subset 3 . In contrast, BATF is required for the differentiation of interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) 2 . BATF3 expression is restricted to conventional DCs and fully differentiated T helper type 1 (T H 1) cells but not to cells of other myeloid or lymphoid lineages. Notably, Batf3 −/− T cells show no apparent defect in their development into any known helper T cell subset. Although BATF is expressed in T H 17 cells, T H 1 cells and T H 2 cells and in activated B cells, the development of T H 1 and T H 2 cells, mature B cells and all DC subsets is normal in Batf −/− mice 2 .
Mice lacking Batf fail to induce the T H 17 transcription factor RORγt and fail to express T H 17-specific cytokines such as IL-17A 2 . BATF not only controls T H 17 development through its regulation of RORγt expression but also directly controls T H 17-specific gene targets, as reconstitution of Batf −/− T cells with RORγt fails to completely restore IL-17 expression. Consistent with that observation, BATF directly binds to regulatory regions surrounding the Il17 locus. The mechanism of gene regulation by BATF seems to arise from the formation of a heterodimer with the transcription factor c-Jun that exerts transcriptionally unique, nonredundant effects on genes encoding molecules involved in T H 17 development.
Immunization of Batf −/− mice with myelin oligodendrocyte glycoprotein peptide fails to induce experimental autoimmune encephalomyelitis, in contrast to its effect on wild-type mice 2 , consistent with a requirement for T H 17 development in experimental autoimmune encephalomyelitis 4 . This defect is due mainly to a T cell-intrinsic property of Batf −/− T cells, as transfer of wild-type T cells into Batf −/− mice restores their ability to manifest severe experimental autoimmune encephalomyelitis after immunization with myelin oligodendrocyte glycoprotein peptide. However, the onset of disease in such mice is delayed slightly relative to its onset in wild-type mice, which suggests additional defects in Batf −/− mice beyond the defect in T H 17 differentiation.
Here we examined Batf −/− mice for the development and activity of lymphocyte populations beyond T H 17 cells. A study of independently generated Batf −/− mice has reported loss of T FH cells, less production of antibodies with switched isotypes and lower expression of activation-induced cytidine deaminase (AID) in B cells 5 . However, that study did not examine the molecular basis of the loss of T FH cell function in Batf −/− mice, nor did it identify the full range of B cellspecific defects involved in class switching. Here we have identified several additional actions of BATF that influence both T FH cell function and class switching in B cells. We show that BATF was required for the expression of two major transcription factors already known to regulate T FH development: Bcl-6 (refs. [6] [7] [8] and c-Maf 9 . Notably, coexpression of both Bcl-6 and c-Maf was required for the restoration of T FH cell activity to Batf −/− T cells. In addition, we found that ectopic expression of AID in Batf −/− B cells did not restore class switching and that BATF was also required for the expression of germline transcripts (GLTs) of the intervening heavy-chain region and constant heavychain region (I H -C H ) initiated from various I-region promoters, A r t i c l e s a known prerequisite for isotype switching 10, 11 . Our results show that BATF functions in vivo as a global regulator of class switching through its dual requirements in T FH cells and B cells and by operating at multiple transcriptional levels in each of these cell types.
RESULTS
Cell-intrinsic T FH cell defects in Batf −/− mice Unimmunized Batf −/− mice had slightly higher serum concentrations of immunoglobulin M (IgM) but much lower concentrations of immunoglobulins of all other isotypes (Supplementary Fig. 1 ). Batf −/− mice had normal antigen-specific IgM production in response to immunization with the T cell-independent hapten trinitrophenylFicoll or the T cell-dependent hapten nitrophenol-chicken γ-globulin but had almost no production of antigen-specific IgG3 or IgG1, respectively (Supplementary Fig. 2 ) and failed to develop peanut agglutinin-positive germinal centers (GCs) in response to immunization with sheep red blood cells (SRBCs; Supplementary Fig. 3a) . B cells from the spleens and Peyer's patches of unimmunized and immunized Batf −/− mice failed to express the cell surface receptor Fas (CD95) or the activation marker GL7, which are characteristic of GC B cells ( Fig. 1a and Supplementary Fig. 3b,c) , whereas T cells from spleen and Peyer's patches lacked expression of the chemokine receptor CXCR5 (Fig. 1b and Supplementary Fig. 3d ), consistent with a defect in follicular helper T cells (T FH cells), a CD4 + T cell subset specialized in providing help to B cells 12, 13 .
To determine whether the loss of switched antibody in Batf −/− mice resulted from a defect in B cells or T cells, we assessed antibody responses after adoptive transfer of mixtures of wild-type or Batf −/− T cells and B cells into recipients deficient in recombination-activating gene 2 (Rag2 −/− ; Supplementary Fig. 4) Fig. 4a ). Antigen-specific IgM was induced under all combinations of T cell and B cell cotransfer (Supplementary Fig. 4b ), but transfer of either wild-type or Batf −/− B cells together with Batf −/− T cells failed to generate antigen-specific IgG responses (Supplementary Fig. 4c ), which suggested that the diminished production of switched antibodies in Batf −/− mice may have resulted from a T cell-intrinsic defect. However, mice that received Batf −/− B cells plus wild-type T cells had significantly less antigen-specific IgG production (P < 0.05; Supplementary  Fig. 4c ), which suggested that Batf −/− mice have a B cell-intrinsic defect in switched antibody responses as well.
We found that Batf −/− mice had considerably fewer CXCR5 + CD4 + T cells not only without immunization, as has been reported before 5 , but also after immunization (Fig. 1b and Supplementary Fig. 5a ).
To determine whether this defect was T cell intrinsic, we transferred wild-type or Batf −/− T cells into normal recipient mice on the SJL background and measured their induction of CXCR5 after immunization ( Fig. 1c and Supplementary Fig. 5c ). Wild-type T cells had high expression of CXCR5 protein, but Batf −/− T cells did not, which suggested that the defect in T FH cells in Batf −/− T mice was T cell intrinsic.
Batf-dependent expression of Bcl-6 and c-Maf by T FH cells
We surveyed global gene expression in wild-type and Batf −/− CD4 + T cells on day 1 or day 3 after in vitro activation in conditions that promote the differentiation of T FH cell-like cells 14 ( Supplementary  Fig. 6 ). There was much lower expression of c-Maf and Bcl-6, each of which is required for T FH differentiation [6] [7] [8] [9] , in Batf −/− CD4 + T cells than in wild-type cells (Fig. 2a) ; the expression of each in Batf −/− CD4 + T cells was approximately 10-20% of that in wild-type T cells, as assessed by both microarray analysis and quantitative realtime PCR (Fig. 2b and 16 , was not altered in Batf −/− T cells (Fig. 2a,b) , which indicated that BATF controls a specific subset of the transcription factors involved in T FH development.
Batf −/− T cells reportedly have a defect in T H 2 development on the basis of quantitative PCR analysis of IL-4 mRNA in T cells from mice on the C57BL/6 background 5 . However, we found that Batf −/− T cells on the BALB/c background that were activated in T H 2-inducing conditions had normal expression of mRNA for the transcription factor GATA-3 and produced wild-type amounts of IL-4 protein (Supplementary Fig. 7 ). These cells also had normal T H 1 development and the expected defect in RORγt expression and T H 17 development 2 . Fig. 8a ). In three highly conserved regions upstream of the Maf promoter (−2.0 to −3.8 kilobases (kb), −4.1 to −4.6 kb, and −4.7 to −5.5 kb; all positions relative to the transcriptional start site), we tested all potential BATF-binding sites with the sequence TGAC/G (where 'G/C' means either G or C) 2 Table 2 ) by electrophoretic mobility-shift assay (EMSA) using with authentic AP-1 probe as a competitor (Fig. 3a) . One region located at position −3.2 kb efficiently competed for BATF binding. By chromatin-immunoprecipitation (ChIP) assay, we found that this region also bound to BATF in vivo in wild-type primary T cells but not in Batf −/− T cells activated in the presence of IL-6 (Fig. 3b) .
(Supplementary
We similarly tested by EMSA all seventeen potential BATF-binding sites in five highly conserved noncoding regions upstream of the Bcl6 promoter ( Supplementary Fig. 8b ). We found that five of these seventeen sites efficiently competed for BATF binding (Fig. 3c) . We tested those five regions by ChIP assay and found that three, located in the proximal promoter and at positions -1.6 kb and -11 kb, also bound to BATF in vivo (Fig. 3d) . The proximal Bcl6 promoter region, which contains a BATF-binding site in vivo, was also functionally responsive to BATF in primary T cells, as its activity was lower in Batf −/− T cells than in wild-type T cells ( Fig. 3e and Supplementary Fig. 9 ). Two upstream regions located between positions −0.98 kb and −2.5 kb (ECR1) and positions −11.3 kb and −11.7 kb (ECR4) and that bound BATF in vivo also showed functional enhancer activity in cooperation with the proximal Bcl6 promoter (Fig. 3f) . In contrast, the two regions that did not bind BATF in vivo by ChIP assay also did not show enhancer activity (Fig. 3f) .
The CD40 ligand (CD40L), ICOS and OX40 are receptors expressed by activated T cells that are involved in the T cell-dependent activation of GC B cells 19 . We determined whether expression of these receptors was altered in Batf −/− T cells (Fig. 4) . After activation by antibody to CD3 (anti-CD3) and anti-CD28, CD40L expression was lower in Batf −/− T cells than in wild-type T cells, whereas expression of ICOS and OX40 was normal (Fig. 4a) . Both the frequency CD40L + T cells (Fig. 4b, left) and amount of CD40L surface expression (Fig. 4b, right) were approximately 40% lower in Batf −/− T cells than in wild-type T cells. This was due to less transcription, as CD40L mRNA was similarly lower in Batf −/− T cells than in control cells (Fig. 4c) , which suggested possible direct involvement of BATF in the control of CD40L expression. In three conserved noncoding regions in the locus encoding CD40L (Supplementary Fig. 8c ), only one of nine potential BATF-binding sites, located in a region −0.367 to −0.392 kb upstream of the proximal promoter, showed strong competition for BATF binding, as assessed by EMSA (Fig. 4d) . 
A r t i c l e s
Bcl-6 and c-Maf restore T FH cell activity to Batf −/− cells We next sought to determine if the requirement for BATF in T FH cell activity was due solely to its control of the expression of Bcl-6 and c-Maf. We expressed various combinations of factors in wild-type or Batf −/− T cells and assessed restoration of CXCR5 expression and T FH cell activity in vivo after adoptive transfer into Rag2 −/− mice (Fig. 5) . Expression of Bcl-6 in wild-type T cells resulted in a higher percentage of T cells expressing CXCR5, but expression of BATF did not (Fig. 5a,b) , and these T cells augmented GC B cell development only slightly (Fig. 5b) , as described before [6] [7] [8] . We next assessed the activity of various factors in restoring T FH cell function when expressed in Batf −/− T cells. BATF-expressing retrovirus restored the surface expression of CXCR5 in Batf −/− T cells to expression similar or greater than that in wild-type T cells (Fig. 5c,d ) and promoted the development of GC B cells, as assayed by expression of Fas and GL7 (Fig. 5c,d) . In contrast, the Bcl-6-expressing retrovirus did not induce higher surface expression of CXCR5 in Batf −/− T cells to the extent that this was induced by BATF, and it failed to promote GC B cell development (Fig. 5c,d) . Likewise, retroviral expression of c-Maf failed to induce CXCR5 expression by Batf −/− T cells or to promote GC B cell development (Fig. 5c,d) . However, coexpression of Bcl-6 together with c-Maf in Batf −/− T cells induced CXCR5 expression to an amount greater than that induced by Bcl-6 alone and promoted significantly more GC B cell development (Fig. 5c,d) .
As expression of Bcl-6 alone in Batf −/− T cells significantly restored CXCR5 expression but did not promote GC B cell development, we sought to determine if c-Maf might contribute to the functional activity of CXCR5-expressing T cells by independently inducing CD40L expression by Batf −/− T cells. For this, we expressed CD40L together with Bcl-6 in Batf −/− T cells and examined their T FH cell activity in vivo (Fig. 5c,d) . Expression of CD40L alone failed to augment CXCR5 expression by T cells or GC B cell development, and when co-expressed with Bcl-6, CD40L failed to augment the effects of Bcl-6 alone. Thus, the action of c-Maf in T FH cell activity does not seem to lie simply in the regulation of CD40L expression and probably involves the control of additional targets. a at 1, 3, 6 , 12 and 24 h after stimulation; results are presented relative to the expression of HPRT mRNA. *P < 0.05 and **P < 0.005 (unpaired Student's t-test). (d) EMSA (as described in Fig. 3a) with double-stranded oligonucleotides from the locus encoding CD40L as competitors (presented above gel as in Fig. 3a) . Data are representative of three (a) or two (d) experiments (a) or are from three (b) or two (c) independent experiments (b; mean and s.e.m.). Fig. 4c) , we examined the secretion and surface expression of antibodies with an in vitro class-switching system (Supplementary Fig. 10a,b) . We found much less of each of the switched isotypes (IgG1, IgG2a, IgG2b, IgG3 and IgA). This defect occurred in vivo, as shown by absent surface expression of IgA on B cells from Peyer's patches and lamina propria (Fig. 6a) , but it was not caused by altered B cell proliferation, a requirement for class switching [20] [21] [22] , or plasmacyte differentiation, as Batf −/− B cells proliferated normally and expressed the plasma cell marker CD138 (syndecan) 23, 24 ( Supplementary Figs. 10c and 11) .
Defective isotype switching was evident at the level of DNA rearrangements (Fig. 6b) . We activated B cells under conditions that induce switching to various isotypes and analyzed their expression of postswitched transcripts (PSTs) encoding the µ-chain intervening region and heavy-chain constant region for each isotype 25 . There was much lower abundance of PSTs of each isotype examined in Batf −/− B cells than in wild-type B cells (Fig. 6b) . This seemed to result from a failure of switching at the level of DNA recombination. For example, for B cells induced to undergo IgG1 switching, wild-type B cells had DNA rearrangements between the µ-chain switch region and γ-chain switch region 1, but we did not detect such DNA rearrangements in Batf −/− B cells (Fig. 6c) .
Although AID expression is reported to be lower in Batf −/− B cells 5 , the basis for this has not been determined. Furthermore, the ability of AID to correct switching defects in Batf −/− B cells has not been demonstrated, so that defects beyond lower AID expression could contribute to the defective class switching in Batf −/− B cells. Therefore, to identify mechanisms that contribute to defective class-switch recombination (CSR), we compared the global gene expression of wild-type and Batf −/− B cells activated in vitro with lipopolysaccharide LPS (Fig. 7a and Supplementary Fig. 12 ). The amount of AID mRNA in Batf −/− B cells was approximately 10% of that in wild-type B cells, as assessed by microarray and quantitative PRC (Fig. 7a,b) . Among 15 additional proteins known to be involved in class switching, expression of AID alone was much lower in Batf −/− B cells (Fig. 7a) . Also, in contrast to T cells, Batf −/− B cells did not have substantially lower expression of any known transcription factors than did wild-type cells (Supplementary Fig. 12 ). For example, expression of Bach2 and IRF4, both of which are required for isotype switching 26, 27 , was not lower in Batf −/− B cells, which suggested that BATF might directly control AID expression rather than controlling the expression of subordinate transcription factors, as it does in T FH cells.
To assess the proposal above, we identified potential TGAC/G BATFbinding sites 2 located in five conserved noncoding regions near the gene encoding AID (Aicda; Supplementary Fig. 13a and Supplementary Table 2 ) and assessed the ability of these sites to compete for BATF binding by EMSA with a consensus AP-1 probe. Nuclear extracts of T cells contained a complex of BATF and the transcription factor JunB that migrated faster than the c-Fos-c-Jun AP-1 heterodimer 2 ; its mobility was shifted with anti-BATF and it was absent from extracts of Batf −/− T cells (Supplementary Fig. 14a ). Extracts of B cells contained that same BATF complex whose mobility was shifted by anti-BATF and that was absent from extracts of Batf −/− B cells ( Supplementary  Fig. 14a ) and was also a heterodimer with JunB, because its mobility was shifted by anti-JunB but not by anti-c-Fos, anti-c-Jun, anti-JunD, anti-ATF1 or anti-ATF3 (Supplementary Fig. 14b) . Notably, the c-Fos-c-Jun AP-1 complex present in T cell extracts was not present in B cells but was replaced by a complex that migrated faster and contained only JunB among the proteins assayed; this perhaps represented a JunB homodimer. The absence of the c-Fos-c-Jun complex from activated B cells may have resulted from loss of c-Fos expression in activated B cells (Supplementary Fig. 14c ), as Fos transcription was essentially extinguished by 1 day after activation, whereas Batf transcription was much higher than its expression in unstimulated B cells.
Of thirteen potential BATF-binding elements in Aicda, one competed very efficiently for BATF binding, as assessed by EMSA (Supplementary Fig. 15 ). This site was located 17 kb downstream of Aicda in a region identified before as being required for AID expression in vivo 28 . Notably, when used directly as an EMSA probe, this site bound to a single complex whose mobility was shifted by anti-BATF and that was missing from Batf −/− B cells extracts and did not bind the JunB homodimer of faster migration that formed with the consensus AP-1 probe (Fig. 7c) . By ChIP analysis, the chromatin region containing this BATF-binding site also bound to BATF in vivo in activated wild-type B cells but not in activated Batf −/− B cells (Fig. 7d) . Furthermore, this same region contained histone H3 highly acetylated at Lys14, a mark of active chromatin, only in wild-type B cells but not in Batf −/− B cells activated by LPS and IL-4 (Fig. 7e) . These results together suggest that BATF may directly regulate AID expression through interactions at the regulatory region located +17 kb downstream of the Aicda transcriptional start site 28 .
To determine if the only role of BATF in CSR is to promote AID expression in activated B cells, we reexpressed AID in Batf −/− B cells by means of a retrovirus and measured isotype switching after in vitro activation with LPS plus IL-4 (Fig. 7f) . As controls, (Fig. 7f) . The AID-expressing retrovirus restored isotype switching to IgG1 in Aicda −/− B cells, as expected, but failed to restore isotype switching to IgG1 in Batf −/− B cells (Fig. 7f) . These results indicate that BATF is required at an additional point in isotype switching beyond its role in AID expression.
I H -C H germline transcription requires BATF CSR requires germline transcription from I-region promoters upstream of each switch region to allow AID access to switch-region DNA [29] [30] [31] [32] . Thus, we examined I H -C H GLTs initiated from various I-region promoters in wild-type and Batf −/− B cells activated under conditions that induce switching to various isotypes (Fig. 8a) . We detected a similar abundance of GLTs initiated from the promoter of the µ-chain I-region gene in both wild-type and Batf −/− B cells, which was expected because Batf −/− B cells express IgM normally. In contrast, the GLTs of all other isotypes were much lower in abundance in Batf −/− B cells than in wild-type B cells (Fig. 8a): γ1GLT (from the γ1 I-region promoter) was 80% less abundant, whereas γ2aGLT and γ2bGLT (from γ2a I-region promoter and γ2b I-region promoter, respectively) were almost completely undetectable. This result suggests that BATF is also required for normal germline transcription of all antibody isotypes. To determine if BATF overexpression could augment GLTs, we transduced empty or BATF-expressing retroviruses into wild-type B cells activated with LPS alone or with interferon-γ (IFN-γ) or transforming growth factor-β (TGF-β) and assayed γ2aGLT, GLTs from the Figure 6d ; expression is normalized to Hprt1 expression and is presented as relative to the expression in Batf +/+ B cells, set as 1. µGLT, GLT initiated from the promoter of the µ-chain I-region gene. *P < 0.005 and **P < 0.0001 (unpaired Student's t-test). A r t i c l e s α-I-region promoter (αGLT) and γ2bGLT (Fig. 8b) . Transduction with retrovirus encoding BATF resulted in more GLT from each I-region promoter than did transduction with empty retrovirus, with the greatest effect on γ2aGLT and αGLT. Transduction with BATFexpressing retrovirus resulted in approximately sixfold more γ2aGLT in B cells activated with LPS plus IFN-γ. When transduced into Batf −/− B cells, BATF-expressing retrovirus restored GLTs to amounts similar to those in wild-type B cells (Fig. 8b) .
To determine whether BATF directly regulates germline transcription from I-region promoters, we examined the activity of the α-chain I-region (I α ) promoter through the use of a reporter construct stably transduced into primary wild-type and Batf −/− B cells (Fig. 8c) . The I α reporter was active in wild-type B cells stimulated with anti-CD40 in the presence of TGF-β and IL-4, but this activity was much lower in Batf −/− B cells activated under the same conditions. This result suggests that the I α promoter is BATF dependent. By ChIP analysis, we detected binding of BATF in vivo to I γ 2b, I γ 2a, and I α promoter regions in wild-type B cells but not Batf −/− B cells (Fig. 8d) . Germline transcription of each C H gene is controlled by elements in the I-region promoters as well as in the 3′ Igh enhancer 29, 30 . In addition, we detected binding of BATF in vivo to the HS3A, HS1,2 and HS3B regions of the 3′ Igh enhancer in wild-type B cells but not Batf −/− B cells (Fig. 8e) . These results suggest that BATF may interact with regulatory elements in I-region promoters and the 3′ enhancer of the Igh locus to control germline transcription.
DISCUSSION
Batf −/− mice have a defect in T H 17 development based on the direct involvement of BATF in the regulation of RORγt and of RORγt target genes, such as Il17a 2 . An independent report has shown Batf −/− mice have less antibody production based on defects in T cells and B cells 5 . Here we determined the molecular mechanisms that underlie the requirement for BATF in CSR on the basis of its action in both T cells and B cells. Moreover, we have now shown that the dual action of BATF shown in T H 17 cells was also evident in its control of the T FH differentiation of T cells and of CSR in B cells.
In T cells, BATF seemed to directly control expression of two of the three main transcription factors recognized as being important for T FH differentiation: the T FH cell 'master factor' Bcl-6 and the basic leucine zipper transcription factor c-Maf 13 . Batf −/− T cells had much lower expression of Bcl-6 and c-Maf. Coexpression of Bcl-6 and c-Maf in Batf −/− T cells partially restored T FH cell activity in vivo, but it is likely that additional direct BATF targets remain to be identified that will explain the residual T FH cell deficit of these Batf −/− T cells. In B cells, BATF was required for CSR not only because it directly controlled AID expression but also because it was required for normal I H -C H germline transcription through all target isotype switch regions via direct interactions with I-region promoters and elements of the 3′ Igh enhancer. Although lower AID expression has been used to explain the diminished isotype switching in Batf −/− B cells 5 , we discovered an additional defect that prevented CSR even when AID expression was restored. These findings substantially broaden the understanding of how BATF regulates antibody production.
In T FH cells, BATF is required for expression of the two critical T FH cell-specific transcription factors Bcl-6 and c-Maf. Bcl-6 is required for normal T FH cell differentiation and function, as Bcl6 −/− T cells fail to express CXCR5 or to support GC formation [6] [7] [8] . Overexpression of Bcl-6 causes upregulation of T FH cell markers in vitro and in vivo, including CXCR5, ICOS and PD-1, and induces T FH differentiation in vivo [6] [7] [8] . Until now, Bcl-6 was thought to be both necessary and sufficient for the development of T FH cells. We have now shown that Bcl-6 was insufficient for T FH cell development in the absence of BATF. A published report has also documented an important role for c-Maf in T FH differentiation 9 . Ablation of c-Maf results in fewer CXCR5 + CD4 + T cells and lower IL-21 expression 9 , whereas overexpression of c-Maf enhances IL-21 expression 33 , which may promote T FH cell development or population expansion. Thus, by controlling the expression of both Bcl-6 and c-Maf, BATF acts at the top of a transcriptional hierarchy that controls T FH differentiation.
In B cells, BATF also acts at two hierarchical levels to control CSR. BATF is required for AID expression, as reported before 5 , which we have now shown is probably due to binding to the required enhancer at located 17 kb downstream of the Aicda transcription start site. In addition, we have shown that BATF was required for transcription through the switch regions, which seemed to involve direct interactions with both I-region promoters and elements of the 3′ enhancer of the Igh locus. Germline transcription was required for CSR to allow access of AID to DNA to induce targeted DNA breaks in the switch regions. Re-expression of AID in Batf −/− B cells by means of a retrovirus did not restore CSR, probably because of insufficient amounts of GLTs from I-region promoters. BATF seems to physically associate with most of the I-region promoters and with several regions of the 3′ enhancer, which are themselves required for GLTs and CSR 34 .
It is notable that the small members of the AP-1 family, BATF and BATF3, exert such specific and lineage-restricted actions 1,2,5 , because they had been thought to act simply as negative regulators of AP-1 activity [35] [36] [37] . BATF3 expression is restricted mainly to DCs, and Batf3 −/− mice have a defect in the development of a subset of DCs. BATF acts more broadly, being required for T H 17 cells and T FH cells, which notably both require IL-6 for their development 18, 38 , and many genes regulated by BATF in T cells are dependent on IL-6 for their induction 2 . The challenge now is to understand how BATF and BATF3 exert their specific transcriptional effects distinctly from other AP-1 family members such as c-Fos and Atf3, which are unable to substitute for BATF and BATF3 in their cell type-specific actions.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/. Accession codes. GEO: microarray data, GSE28736.
